Werewolf Therapeutics, Inc. (HOWL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 48.73M | 58.59M | 68.17M | 80.44M | 94.46M | 113.07M | 125.83M | 138.79M | 142.28M | 138.37M | 130.06M | 147.4M |
| Cash & Short-Term Investments | 46.45M | 57.05M | 65.71M | 77.6M | 92.04M | 111M | 122.83M | 135.3M | 139.19M | 134.34M | 130.06M | 137.45M |
| Cash Only | 46.45M | 57.05M | 65.71M | 77.6M | 92.04M | 111M | 122.83M | 135.3M | 139.19M | 134.34M | 130.06M | 137.45M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200K | 775K | 1.35M | 5.91M | 5.2M |
| Days Sales Outstanding | - | - | - | - | - | - | - | 38.81 | 130.31 | 222.52 | 86.67 | 64.5 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.99M | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 2.28M | 1.54M | 0 | 0 | 2.42M | 2.07M | 464K | 345K | 2.32M | 2.68M | 3.08M | 1.93M |
| Total Non-Current Assets | 9.29M | 10.81M | 11.45M | 12.13M | 12.78M | 13.86M | 14.2M | 14.91M | 35.32M | 36.46M | 37.13M | 37.84M |
| Property, Plant & Equipment | 9.29M | 9.9M | 10.51M | 11.11M | 11.71M | 12.32M | 12.94M | 13.44M | 14.04M | 14.85M | 15.59M | 16.17M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 0.08x | 0.05x | 0.10x | 0.37x | 0.49x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 891K | 1.22M | 0 | 0 | 21.03M | 21.02M | 21.02M | 0 |
| Other Non-Current Assets | 0 | 906K | 944K | 1.02M | 179K | 320K | 1.26M | 1.48M | 248K | 594K | 516K | 21.67M |
| Total Assets | 58.02M | 69.4M | 79.63M | 92.57M | 107.24M | 126.93M | 140.04M | 153.7M | 177.6M | 174.83M | 176.39M | 185.24M |
| Asset Turnover | - | - | - | - | - | - | - | 0.01x | 0.00x | 0.01x | 0.03x | 0.04x |
| Asset Growth % | -45.89% | -45.33% | -43.14% | -39.78% | -39.62% | -27.4% | -20.61% | -17.02% | -8.96% | 9.1% | 2.3% | 5.65% |
| Total Current Liabilities | 38.52M | 36.15M | 17.6M | 15.17M | 11.67M | 15.18M | 12.46M | 11.44M | 21.21M | 19.38M | 14.44M | 15.01M |
| Accounts Payable | 3.57M | 754K | 1.08M | 2.77M | 986K | 3.04M | 1.24M | 1.47M | 1.59M | 1.34M | 1.39M | 1.49M |
| Days Payables Outstanding | 488.78 | - | - | 421.38 | 424.75 | - | - | 306.77 | 287.32 | 272.2 | 297.29 | - |
| Short-Term Debt | 30.43M | 28.24M | 6M | 2.4M | 0 | 0 | 0 | 0 | 11.67M | 6.67M | 1.67M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 502K | 907K | 1.81M | 0 |
| Other Current Liabilities | 4.33M | 302K | 0 | 182K | 1.63M | 3.62M | 451K | 59K | 4.87M | 5.23M | 950K | 2.15M |
| Current Ratio | 1.27x | 1.62x | 3.87x | 5.30x | 8.09x | 7.45x | 10.10x | 12.13x | 6.71x | 7.14x | 9.01x | 9.82x |
| Quick Ratio | 1.27x | 1.62x | 3.87x | 5.30x | 8.09x | 7.45x | 10.10x | 12.13x | 6.71x | 7.14x | 9.63x | 9.82x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.3M | 8.44M | 32.41M | 35.93M | 38.26M | 38.36M | 38.19M | 38.24M | 38.8M | 44.08M | 49.5M | 51.63M |
| Long-Term Debt | 0 | 0 | 21.66M | 24.7M | 26.59M | 26.09M | 25.62M | 25.16M | 27.75M | 32.66M | 37.56M | 39.14M |
| Capital Lease Obligations | 7.22M | 7.68M | 8.14M | 8.59M | 9.02M | 9.44M | 9.84M | 10.24M | 10.62M | 10.99M | 11.35M | 11.71M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 85K | 759K | 2.61M | 2.64M | 2.66M | 2.83M | 2.73M | 2.84M | 431K | 433K | 588K | 783K |
| Total Liabilities | 45.82M | 44.59M | 50.01M | 51.1M | 49.93M | 53.54M | 50.66M | 49.69M | 60.01M | 63.46M | 63.94M | 66.64M |
| Total Debt | 37.65M | 37.67M | 37.3M | 37.15M | 37.01M | 37.09M | 36.78M | 36.68M | 51.27M | 51.92M | 52.19M | 52.82M |
| Net Debt | -8.8M | -19.38M | -28.41M | -40.45M | -55.03M | -73.91M | -86.05M | -98.63M | -87.92M | -82.42M | -77.87M | -84.64M |
| Debt / Equity | 3.09x | 1.52x | 1.26x | 0.90x | 0.65x | 0.51x | 0.41x | 0.35x | 0.44x | 0.47x | 0.46x | 0.45x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -6.55x | -5.12x | -24.42x | -12.82x | -13.32x | -15.10x | -12.40x | -14.10x | -15.14x | -8.69x | -10.28x | -4.34x |
| Total Equity | 12.2M | 24.8M | 29.61M | 41.46M | 57.31M | 73.39M | 89.38M | 104.02M | 117.59M | 111.37M | 112.44M | 118.6M |
| Equity Growth % | -78.71% | -66.2% | -66.87% | -60.14% | -51.26% | -34.1% | -20.51% | -12.29% | -2.88% | -8.96% | -14.13% | -8.66% |
| Book Value per Share | 0.25 | 0.53 | 0.65 | 0.92 | 1.28 | 1.65 | 2.05 | 2.39 | 2.83 | 3.05 | 3.15 | 3.34 |
| Total Shareholders' Equity | 12.2M | 24.8M | 29.61M | 41.46M | 57.31M | 73.39M | 89.38M | 104.02M | 117.59M | 111.37M | 112.44M | 118.6M |
| Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 3K | 3K |
| Retained Earnings | -488.94M | -475.41M | -467.03M | -450.66M | -432.68M | -414.59M | -394.19M | -377.51M | -360.27M | -344.07M | -332.07M | -323.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |